Li, Jinping
Deng, Zhenyan
Liu, Yu
Jin, Jiamin
Xie, Chichu
Gan, Jinfeng
Funding for this research was provided by:
National Natural Science Foundation of China (32360170, 82360327, 82160590)
The innovative project of Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation
Article History
Received: 17 January 2024
Accepted: 28 May 2024
First Online: 9 June 2024
Declarations
:
: This study involving human TET samples was reviewed and approved by the Ethics Committee of Shanghai YEPCOME Biotechnology Company, and written informed consent was obtained from all patients. The study was conducted according to the Helsinki Declaration.
: The authors declare that they have no competing interests.